Pacific Biosciences
PACB
#8185
Rank
A$0.50 B
Marketcap
A$1.63
Share price
-2.95%
Change (1 day)
-15.79%
Change (1 year)

Pacific Biosciences (PACB) - Cash on Hand

Cash on Hand as of March 2026 : A$0.39 Billion

According to Pacific Biosciences 's latest financial reports the company has A$0.39 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Pacific Biosciences - Cash on Hand chart (from 2009 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31A$0.41 B-33.43%
2024-12-31A$0.62 B-32.36%
2023-12-31A$0.92 B-18.34%
2022-12-31A$1.13 B-21.22%
2021-12-31A$1.44 B247.45%
2020-12-31A$0.41 B491.24%
2019-12-31A$70.12 M-51.73%
2018-12-31A$0.14 B80.41%
2017-12-31A$80.53 M-19.35%
2016-12-31A$99.85 M-11.58%
2015-12-31A$0.11 B-8.81%
2014-12-31A$0.12 B-1.84%
2013-12-31A$0.12 B30.34%
2012-12-31A$96.78 M-44.07%
2011-12-31A$0.17 B-38.04%
2010-12-31A$0.27 B170.52%
2009-12-31A$0.10 B-31.32%
2008-12-31A$0.15 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Thermo Fisher Scientific
TMO
A$4.61 B 1,079.87%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$13.23 B 3,286.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.63 B 318.54%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
A$3.48 B 791.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Luminex
LMNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
A$0.13 B-64.81%๐Ÿ‡บ๐Ÿ‡ธ USA